Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-022759
Filing Date
2025-02-07
Accepted
2025-02-07 16:33:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d876785ds3.htm S-3 389457
2 EX-5.1 d876785dex51.htm EX-5.1 35085
3 EX-23.1 d876785dex231.htm EX-23.1 1400
4 EX-FILING FEES d876785dexfilingfees.htm EX-FILING FEES 57875
5 GRAPHIC g876785dsp52a.jpg GRAPHIC 2950
6 GRAPHIC g876785g35x97.jpg GRAPHIC 35746
  Complete submission text file 0001193125-25-022759.txt   538413
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284774 | Film No.: 25602381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)